Lipoic acid/Mecobalamin/Vitamin B1/Vitamin B6

硫辛酸/甲钴胺/维生素B1/维生素B6

Report date: 2025/05/15 20:00:08

Base Information

Drug NameLipoic acid/Mecobalamin/Vitamin B1/Vitamin B6
Drug Alias NameAlpha-Lipoic Acid/Vitamin/Mineral Supplement PolyMVABionerv
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase kinase stimulantsDNA (cytosine-5)-methyltransferase 1 stimulantsVitamin B1 supplements
TargetsPyruvate dehydrogenase kinaseDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMalaysia
CombinationsYes Lipoic acidMecobalaminVitamin B1
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBREGO Life Sciences Sdn Bhd
China Registration ClassN/A

Develop Information

Active CompaniesBREGO Life Sciences Sdn Bhd
Inactive CompaniesN/A
Active IndicationsDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A